HIGHLIGHTS
SUMMARY
Prediction of immunotherapy response also suggested that low-risk group could benefit better from immunotherapy. Overall, this study found that CMRGS can help predict the prognosis of patients with LUAD and may guide immunotherapy. Construction and validation of CMRGS Analysis of TMB First, univariate cox regression analysis was performed on the differentially expressed CMRGs. Patients were divided into high- or low-risk groups based on the median risk score. The same formula was used to calculate the risk score for each patient, and KM survival analysis was performed by "survival" and "survminer" package. Prognostic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.